Brain Advance Access published online on February 15, 2006
Brain, doi:10.1093/brain/awl041
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 INSERM U679, Neurology and Experimental Therapeutics, Faculty of Medicine, Paris, France; Salpetriere Hospital, Faculty of Medicine, Paris, France; Pierre and Marie Curie University, Faculty of Medicine, Paris, France
* To whom correspondence should be addressed. We investigated whether there is neurogenesis in the striatum of aged monkeys, and whether dopamine (DA) depletion induces the genesis of new DA neurons in this structure. Six aged macaques received repeated intraperitoneal injections of bromodeoxyuridine (BrdU) over a 3 week period to label dividing cells. Three macaques were injected in parallel with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to decrease dopaminergic innervation of the striatum. The brains were analysed 3 weeks after the last BrdU injection. In MPTP-treated aged macaques, the number of tyrosine hydroxylase (TH) immunoreactive (ir) striatal neurons increased 2.3-fold compared with controls. These TH-ir striatal cells did not express dopamine beta hydroxylase (DBH) but the dopamine transporter (DAT), suggesting that they are functional DA neurons. They were also negative for calbindin (CB), neuropeptide Y (NPY) and parvalbumin (PV), and a small proportion expressed calretinin (CR). This suggests that these cells stained for TH are interneurons. All these cells also co-expressed glutamic acid decarboxylase (GAD). They thus resemble the small, aspiny, GABAergic interneurons. None of the BrdU-labelled cells in the striatum expressed the neuronal markers neuronal nuclei (NeuN), or GAD or TH, and none of TH-ir cells incorporated BrdU. These data indicate that neurogenesis did not occur in the striatum of aged macaques. The new striatal TH-ir neurons observed after DA depletion was therefore derived from pre-existing GABAergic interneurons. Understanding of the molecular signals mediating this phenotypic shift might help in developing novel and elegant strategies for a cell-based therapy for Parkinson's disease that would avoid many of the drawbacks of cell transplantation.
Received November 8, 2005
Revised January 13, 2006
Accepted January 24, 2006
Article
New striatal dopamine neurons in MPTP-treated macaques result from a phenotypic shift and not neurogenesis
Dominique Tandé 1,
Günter Höglinger 2,
Thomas Debeir 1,
Nils Freundlieb 2,
Etienne C. Hirsch 1,
and
Chantal François 1 *
2 Department of Neurology, Experimental Neurology Unit, Philipps University, Marburg, Germany
Chantal François, E-mail: cfrancoi{at}ccr.jussieu.fr
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. S. Kim, J. H. Shin, F. S. Hall, and D. J. Linden Dopamine Signaling Is Required for Depolarization-Induced Slow Current in Cerebellar Purkinje Cells J. Neurosci., July 1, 2009; 29(26): 8530 - 8538. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kowsky, C. Poppelmeyer, E. R. Kramer, B. H. Falkenburger, A. Kruse, R. Klein, and J. B. Schulz RET signaling does not modulate MPTP toxicity but is required for regeneration of dopaminergic axon terminals PNAS, December 11, 2007; 104(50): 20049 - 20054. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. San Sebastian, J. Guillen, M. Manrique, S. Belzunegui, E. Ciordia, A. Izal-Azcarate, P. Garrido-Gil, M. Vazquez-Claverie, and M. R. Luquin Modification of the number and phenotype of striatal dopaminergic cells by carotid body graft Brain, May 1, 2007; 130(5): 1306 - 1316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Huot, M. Levesque, and A. Parent The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea Brain, January 1, 2007; 130(1): 222 - 232. [Abstract] [Full Text] [PDF]
|
|